<DOC>
	<DOCNO>NCT00488384</DOCNO>
	<brief_summary>Acitretin give hemodialysis patient develop in-situ invasive squamous cell carcinoma skin increase dos 25 mg daily one year .</brief_summary>
	<brief_title>Acitretin Plasma Levels Under Hemodialysis</brief_title>
	<detailed_description>Acitretin give hemodialysis patient develop in-situ invasive squamous cell carcinoma skin increase dos 25 mg daily one year . Plasma level acitretin monitor influence hemodialysis acitretin plasma level determine . Number in-situ invasive squamous cell carcinoma skin case determine . - Trial medicinal product</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Acitretin</mesh_term>
	<criteria>Inclusion criterion : Hemodialyis patient least one case insitu invasive squamous cell carcinoma skin Exclusion criterion : Hepatopathy Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Squamous cell carcinoma skin hemodialysis</keyword>
</DOC>